Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Osteoarthritis Market Growth Performance Trended Historically, And What Lies Ahead?

Over recent years, the market size for osteoarthritis has seen significant expansion. The market value is predicted to rise from $6.87 billion in 2024 to $7.49 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.1%. The previous growth periods owe their progress to factors like the rising elderly population, increasing obesity epidemic, advancements in imaging techniques, and improved pain management.

The market size for osteoarthritis is predicted to witness robust growth in the coming years. The market is expected to expand to an estimation of$10.74 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.4%. The reasons for growth during the forecasted timeframe include the use of non-pharmacological methods, disease-altering osteoarthritis drugs (dmoads), personalized treatment, telehealth services, and remote patient monitoring. Other trending factors over the forecast period include the advent of regenerative therapies, the use of wearable medical devices, the incorporation of artificial intelligence in diagnostics, and digital health solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Are the Core Growth Drivers Propelling the Osteoarthritis Market Forward?

The surge in obesity-related diseases is anticipated to fuel the expansion of the osteoarthritis market. Obesity-related conditions encompass numerous health complications resulting from an excess of body fat. It’s generally caused by taking in more calories than your body can burn during physical activity and workouts, or from excessive consumption of processed foods, fast foods, and alcohol. Obesity can exacerbate osteoarthritis by placing additional strain on joints, causing inflammation, and disrupting hormone regulation, which ultimately increases the burden on the joints. For example, the World Obesity Atlas 2022, produced by the UK’s non-profit World Obesity Federation, predicts that by 2030, 1 billion people globally (including 1 in 7 men and 1 in 5 women) will be obese. By 2035, this number is estimated to increase to 4 billion people, equating to 51% of the global population, either overweight or obese. Consequently, the surge in obesity-related diseases is propelling the osteoarthritis market’s growth.

What Segment Types Define the Osteoarthritis Market Structure?

The osteoarthritismarket covered in this report is segmented –

1) By Treatment: Medication; Surgery; Therapy

2) By Diagnosis: Imaging; Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route

4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis

5) By End-User: Hospitals; Medical Institutes

Subsegments:

1) By Medication: Pain Relievers; Corticosteroids; Hyaluronic Acid Injections; Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery; Arthroscopy; Osteotomy; Joint Fusion

3) By Therapy: Physical Therapy; Occupational Therapy; Weight Management Programs; Assistive Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Osteoarthritis Market?

North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Emerging Trends that Are Influencing theOsteoarthritis Industry Evolution?

Leading companies in the osteoarthritis market are leveraging strategic partnerships to improve their technological capabilities and broaden their market presence. This kind of partnership usually involves a cooperative relationship among two or more companies, pooling their resources, knowledge, and efforts to attain shared goals. For instance, in July 2024, LG Chem, a pharmaceutical firm based in South Korea, penetrated the Chinese market by partnering with Yifan Pharmaceutical Co., Ltd., a pharma research and manufacturing company based in China. Their collective effort led to the introduction of the Synovian injection for osteoarthritis, which mirrors the therapeutic effects of traditional multi-injection formulations with just a single administration. Synovian comes with unique characteristics like its incredibly high molecular weight (10 million Dalton) hyaluronic acid that boosts viscoelasticity and joint operation, and its proven ability to dramatically lessen knee pain as per the results from the clinical phase 3 trial. These developments place Synovian on the map as a promising solution for people looking for efficient relief from osteoarthritis symptoms.

View the full report here:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

What Is the Definition of the Osteoarthritis Market?

Osteoarthritis is a form of arthritis that solely affects the joints, typically the hands, knees, hips, neck and lower back. It develops when the cartilage that covers and shields the ends of the bones gradually erodes. Osteoarthritis treatment aims to reduce pain, improve joint function and slow down the progression of the disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model